Sorrento Therapeutics, Inc. SAN DIEGO and PALO ALTO, Calif., April 28, 2022 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics,…
Sorrento Therapeutics, Inc. SAN DIEGO and PALO ALTO, Calif., April 28, 2022 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics,…